Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after ...

The burger giant reported its U.S. same-store sales increased 2.4% for the three months ended Sept. 30, faster growth than analysts had forecast. Drug Distributor Cencora to Invest $1 Billion in U.S.

Frontier Scientific Solutions is creating the nation’s first “scheduled service” flights for the pharmaceutical and ...

The latest update is out from Mayne Pharma Group ( (AU:MYX) ).

IGC Pharma (IGC) announced an expansion of its AI-powered in-Silico drug discovery platform. The company is now integrating more methodologies, ...

(Reuters) -AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq ...

The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, ...

Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after posting better-than-expected results for the third quarter, banking on strong demand for its components ...

J&J lifts full-year sales guidance to as much as $93.9 billion, topping Wall Street forecasts. Orthopedics unit DePuy Synthes to be spun off within 24 months. Strong oncology and immunology sales ...

Global growth is projected at 3.0 percent for 2025 and 3.1 percent in 2026, an upward revision from the April 2025 World Economic Outlook. This reflects front-loading ahead of tariffs, lower effective ...